LEP and metabolic dysfunction-associated steatohepatitis: Thus, the concomitant increase in expression of gastric CNR1 and LEP in patients with hepatic inflammation seen in this study may be another indication of contribution of peripheral leptin resistance to obesity-associated NASH.